Drugs dispensed in primary care during pregnancy: A record-linkage analysis in tayside, Scotland

Drug Safety

Volumn 33, Issue 7, 2010, Pages 593-604

  Irvine, Linda ^a   Flynn, Robert W V ^b   Libby, Gillian ^c   Crombie, Iain K ^a   Evans, Josie M M ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c King's Cross Hospital   (United Kingdom)

^d UNIVERSITY OF STIRLING   (United Kingdom)

Author keywords

Pharmacovigilance; Postmarketing surveillance; Pregnancy; Prescribing; Teratogenesis

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; BECLOMETASONE; CLOMIFENE; CODEINE; CORTICOSTEROID; DIAZEPAM; ESTRADIOL; FLUOXETINE; FLUTICASONE PROPIONATE; FOLIC ACID; IRON; LAXATIVE; MEDROXYPROGESTERONE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PROCHLORPERAZINE; SALBUTAMOL; SEX HORMONE; TEMAZEPAM; PRESCRIPTION DRUG;

ADULT; ARTICLE; CONCEPTION; DRUG CONTRAINDICATION; DRUG SAFETY; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; FETUS; FETUS RISK; FOOD AND DRUG ADMINISTRATION; HORMONE SUBSTITUTION; HUMAN; INDIGESTION; LOW DRUG DOSE; MATERNITY WARD; MENSTRUAL CYCLE; METRORRHAGIA; NICOTINE REPLACEMENT THERAPY; PREGNANCY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; STILLBIRTH; THIRD TRIMESTER PREGNANCY; UNITED KINGDOM; ADOLESCENT; DRUG USE; EPIDEMIOLOGY; MEDICAL RECORD; MIDDLE AGED; PREGNANCY OUTCOME; PRIMARY HEALTH CARE; STANDARDS; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; YOUNG ADULT;

ADOLESCENT; ADULT; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; MEDICAL RECORD LINKAGE; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTERS; PRESCRIPTION DRUGS; PRIMARY HEALTH CARE; SCOTLAND; YOUNG ADULT;

EID: 77953594954     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11532330-000000000-00000     Document Type: Article

References (33)

1. Engeland A, Bramness JG, Daltveit AK, et al. Prescription drug use among fathers and mothers before and during pregnancy: a population-based cohort study of 106,000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol 2008; 65: 653-660
2. Gagne JJ, Maio V, Berghella V, et al. Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol 2008; 64: 1125-1132
3. Bakker MK, Jentink J, Vroom F, et al. Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG 2006; 113: 559-568
4. Riley EH, Fuentes-Afflick E, Jackson RA, et al. Correlates of prescription drug use during pregnancy. J Womens Health 2005; 14: 401-409
5. Schirm E, Meijer WM, Tobi H, et al. Drug use by pregnant women and comparable non-pregnant women in the Netherlands with reference to the Australian classification system. Eur J Obstet Gynecol Reprod Biol 2004; 114: 182-188
6. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004; 191: 398-407
7. Egen-Lappe V, Hasford J. Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 2004; 60: 659-666
8. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, et al. Prescription of drugs during pregnancy in France. Lancet 2000; 356: 1735-1736
9. Shehata HA, Nelson-Piercy C. Drugs in pregnancy: drugs to avoid. Best Pract Res Clin Obstet Gynaecol 2001; 15: 971-986
10. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 16: 1128-1137
11. Little BB. Drugs and pregnancy: a handbook. London: Hodder Arnold, 2007
12. Webster WS, Freeman JA. Prescription drugs and preg-nancy. Expert Opin Pharmacother 2003; 4: 949-961
13. Weiner CP, Buhimschi C, Swaan P. Drug-prescribing chal-lenges during pregnancy. Curr Obstet Gynaecol 2005; 15: 157-165
14. Mitchell AA. Systematic identification of drugs that cause birth defects: a new opportunity. N Engl J Med 2003; 349: 2556-2559
15. Evans JMM, McDevitt DG, MacDonald TM. The Tayside Medicines Monitoring Unit (MEMO): a record-linkage system for pharmacovigilance. Pharmaceut Med 1995; 9: 177-184
16. British National Formulary. London: BMJ Group and RPS Publishing, 2007 17. Office of the Chief Statistician. Scottish index of multiple deprivation 2004: summary technical report. Edinburgh: Scottish Executive, 2004 [online]. Available from URL: http://www.scotland.gov.uk/library5/society/siomd.pdf [Accessed 2010 May 4]
17. ISD Scotland. Health and social care data dictionary [online]. Available from URL: http://www.datadictionary admin.scot.nhs.uk/isddd/1733.html [Accessed 2010 May 4]
18. Department of Health and Human Services, Food and Drug Administration. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Fed Regist. 2008, 73: 30831-30868
19. Colvin L, Slack-Smith L, Stanley FJ, et al. Pharmaco-vigilance in pregnancy using population-based linked data-sets. Pharmacoepidemiol Drug Saf 2009; 18: 211-225
20. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 7th ed. Philadelphia (PA): Lippincott, Williams and Wilkins, 2005
21. Physicians' desk reference. 58th ed. Montvale (NJ): Thom-son PDR, 2004
22. Spratto GR, Woods AL. PDR nurse's drug handbook. Montvale (NJ): Thomson PDR, 2006
23. Drugs.com. Drug information online 2000-2009 [online]. Available from URL: http://www.Drugs.com [Accessed 2010 May 4]
24. Lee E, Maneno MK, Smith L, et al. National patterns of medication use during pregnancy. Pharmacoepidemiol Drug Saf 2006; 15: 537-545
25. Wen SW, Yang T, Krewski D, et al. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population. J Perinatol 2008; 28: 324-329
26. Andrade SE, Raebel MA, Morse AN, et al. Use of pre-scription medications with a potential for fetal harm among pregnant women. Pharmacoepidemiol Drug Saf 2006; 15: 546-554
27. Cooper WO, Hickson GB, Ray WA. Prescriptions for con-traindicated category X drugs in pregnancy among women enrolled in TennCare. Paediatr Perinat Epidemiol 2004; 18: 106-111
28. Hardy JR, Leaderer BP, Holford TR, et al. Safety of medi-cations prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database. Pharmacoepidemiol Drug Saf 2006; 15: 555-564
29. Malm H, Martikainen J, Klaukka T, et al. Prescription of ha-zardous drugs during pregnancy. Drug Saf 2004; 27: 899-908
30. Olesen C, Sørensen HT, de Jong-van den Berg L, et al. Pre-scribing during pregnancy and lactation with reference to the Swedish classification system: a population-based study among Danish women. Acta Obstet Gynecol Scand 1999; 78: 686-692
31. De Vigan C, De Walle HE, Cordier S, et al. Therapeutic drug use during pregnancy: a comparison in four European countries. OECM Working Group. Occupational Exposures and Congenital Anomalies. J Clin Epidemiol 1999; 52: 977-982
32. Anderson S, Bradshaw P, Cunningham-Burley S, et al. Growing up in Scotland: a study following the lives of Scotland's children. Edinburgh: Scottish Centre for Social Research and the Centre for Research on Families and Relationships, 2007 [online]. Available from URL: http://www.scotland.gov.uk/ Resource/Doc/163083/0044329.pdf [Accessed 2010 May 4]
33. Haramburu F, Miremont-Salame G, Moore N. Good and bad drug prescription in pregnancy. Lancet 2000; 356: 1704